Papers/PMID:28295905
Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials.
Obesity reviews : an official journal of the International Association for the Study of Obesity2017The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
lipoic acid — decreases body mass
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Overall weight loss was 1.27 kg (CI=-2.29 to -0.25) greater in ALA treatment compared to that in placebo group.”
Quoted verbatim from Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- 300 to 1800 mg/day across trials
- Population
- Adults in eight randomised, double-blind, placebo-controlled trials reporting weight, including patients with diabetes mellitus, metabolic syndrome, rheumatoid arthritis, non-alcoholic fatty liver disease and overweight or obesity; durations 8 to 52 weeks
Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials.2017PMID:28295905Permalink